Back to search

Article

Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult Population

2024-12-18

Abstract excerpt

<title>Abstract</title> <p><bold>Introduction</bold> Metabolic dysfunction associated steatotic liver disease (MASLD) has replaced NAFLD as the diagnostic standard. This study aimed to validate steatosis and fibrosis non-invasive tests (NITs) used for NAFLD in predicting MASLD and advanced fibrosis, compared to transient elastography (TE), respectively. <bold>Methods</bold> This cross-sectional study used the NHA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
68da136b-2f87-5ebd-ac64-bc911c41bf3b
DOI
10.21203/rs.3.rs-5456895/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationDOI 10.21203/rs.3.rs-5456895/v1
Select a neighboring publication to make it the new centre.